[1] She was known for her advocacy for human rights and women's health, and for her research applying a feminist perspective to biotechnology and pharmaceutical drugs.
Among her most notable works were her critiques of hormone replacement therapy, the pharmaceutical industry, the HPV vaccine, and the "geneticization" of reproductive technologies.
[2][3] In 2001, Lippmann helped the Center for Genetics and Society (CGS) to continue their efforts to bring social justice on human biotechnology.
[6] She was highly involved in political issues relating women's health as well as her studies of applied in genetic technologies.
[7] Lippman gave her first professional presentation in 1975 when she participated in the March of Dimes-Birth Defects Conference in San Francisco, United States.